London, 13 February 2015 – The increasing incidence of organ failure has resulted in the growth of the Global Transplantation Market, which is expected to post a CAGR of 9.36 percent from 2014-2019, says research firm TechNavio.
About the Report
According to the latest report from TechNavio, demand for tissue and organs like bone marrow, hearts, livers, kidneys and lungs is high, and growing worldwide. A rise in the global aging population is also resulting in the increased demand for organs for transplantation.
“More and more organ failures have impacted the demand for tissue products, immunosuppressants and organ preservation solutions,” says Faisal Ghaus, Vice President of TechNavio.
The new report also draws attention towards increased government and NGO initiatives to encourage people to donate organs. The gap between the demand and supply of organs for transplantation has increased over the last decade. However, new guidelines for organ donation make the process more transparent and accessible.
“In 2013, the Australian government conducted a national reform program to increase organ donation and transplantation, which led to a rise in the number of organ donations from the previous year,” says Ghaus.
These factors are all expected to have a significant impact on the growth rate of the Global Transplantation Market over the forecast period.
Key Information Covered in the Report:
Market segmentation, size and forecast through 2019
Market Growth Drivers:
- Increased Incidence of Organ Failure
- For a full detailed list, view our report.
Market Challenges:
- Transplant Rejection
- For a full detailed list, view our report.
Market Trends:
- Increased Government and NGO Initiatives
- For a full detailed list, view our report.
Key Vendors:
- Abbott Laboratories
- Arthrex
- Biomet
- Medtronic
Other Prominent Vendors:
- Aastrom Biosciences
- Bacterin International
- Bellicum Pharmaceuticals
https://www.technavio.com/%3Cp%3E%3Ca%20href%3D%22http%3A//www.technavio….
